CTIS2024-511388-27-04招募中1 期
Add-on Clioquinol in drug-resistant epilepsy: an exploratory study - CLIOKIDA
Z Leuven0 个研究点目标入组 20 人开始时间: 2024年7月8日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 64(—)
- 性别
- All
入选标准
- •Drug-resistant epilepsy: = 4 seizures in the 2 week prospective period (baseline) before visit 2, not all (4) seizures observed in 1 of the 2 weeks. Baseline period can be extended with 1 or 2 weeks., Age = 12 years and < 35 years at time of inclusion, Drug-resistant epilepsy: before inclusion failure of at least 2 AEDs, The patient is at the moment of inclusion on max 3 anti-epileptic drugs (VNS and ketogenic diet not included), Well defined epilepsy history with convulsive seizures (with observable and countable motor component)
排除标准
- •Presence of C609T NQO1 SNP after SNP analysis of NQO1 based on a blood sample during baseline visit (visit 1) by Genomics Core, Asian etnicity, Abnormal low blood level of vitamin B12 or Zn
研究者
相似试验
进行中(未招募)
2 期
Add-on Clioquinol in Drug-resistant Childhood Epilepsy: an Exploratory StudyEpilepsy IntractableNCT05727943KU Leuven10
进行中(未招募)
1 期
Administering Clioquinol to children with drug-resistant epilepsyDrug resistant epilepsy in childrenMedDRA version: 21.0Level: PTClassification code 10015037Term: EpilepsySystem Organ Class: 10029205 - Nervous system disordersEUCTR2020-004511-27-BEniversity Hospital Leuven20
已完成
不适用
Reduction of concomitant antiepileptic medication after successful treatment with levetiracetam; a randomised open label study comparing delayed withdrawal to slow withdrawal.EpilepsyISRCTN72533351Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
进行中(未招募)
不适用
Influence on quality of life of various treatment choices of people with drug-resistant epilepsyEpilepsyISRCTN56117572Cornwall Partnership NHS Foundation Trust150
招募中
不适用
Stiripentol (diacomit(R)) for refractory epilepsy patients with autoimmune encephalitisrefractory epilepsyJPRN-UMIN000023741agoya City University6
